Agenda - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (18 September 2024)
Pharmacovigilance Risk Assessment Committee (PRAC) criteria to prioritise impact research (Rev.1)
Veterinary medicines European public assessment report (EPAR): Dexdomitor, dexmedetomidine, Status: Authorised
Recommended submission dates for veterinary medicinal products
Agenda - Information session on the pilot for expert panels' advice for orphan medical devices
Lidocaine (bovine): European Public MRL Assessment Report (EPMAR) - CVMP
Lidocaine (porcine species): European Public MRL Assessment Report (EPMAR) - CVMP
Decision of the Executive Director on transparency measures for senior staff leaving the Agency
Joint Committee Opinion 27/2020 on criteria and restrictions for senior staff applying for occupational activities within two years after leaving the Agency
Establishing efficacy based on single-arm trials submitted as pivotal evidence in a marketing authorisation